ActivePhase 4ACTRN12606000004561

International, multicentre: Perhexiline in Aortic Stenosis study.

Effects of perhexiline on the symptomatic status in elderly patients with severe aortic stenosis.

Sponsor

The Queen Elizabeth Hospital,Cardiology Department

Enrollment

65 participants

Start Date

Jun 1, 1999

Study Type

Interventional

Conditions

Sever aortic stenosis.

Summary

Too see if perhexilin can decrease the symptoms of chest pain and breathlessness in people who have severe aortic stenosis.

Eligibility

Sex: Both males and females

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying International, multicentre: Perhexiline in Aortic Stenosis study.. Eligibility depends on specific medical criteria that the study team will evaluate. Participation typically involves medical assessments, possible treatment with the study intervention, and follow-up visits to track your health.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Perhexiline 100mgs BD for 8 weeks.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000004561